NCT05884190

Brief Summary

The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,030

participants targeted

Target at P75+ for not_applicable

Timeline
17mo left

Started Jun 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jun 2023Oct 2027

First Submitted

Initial submission to the registry

May 22, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 1, 2023

Completed
11 days until next milestone

Study Start

First participant enrolled

June 12, 2023

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

April 9, 2025

Status Verified

April 1, 2025

Enrollment Period

4.3 years

First QC Date

May 22, 2023

Last Update Submit

April 7, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in mean postpartum systolic blood pressure (SBP) at 6 weeks

    Change in mean postpartum systolic blood pressure (SBP) at 6 weeks. A reduction in SBP indicates an improvement in postpartum hypertension.

    6 weeks

  • Depression severity at 3 months postpartum assessed using the Edinburgh Postnatal Depression Scale (EPDS).

    EPDS is a 10-item validated scale that measures depressive symptoms and is designed for use with pregnant and postpartum women. Scoring: None or minimal depression (0-6), Mild depression (7-13), Moderate depression (14-19), Severe depression (19-30). A reduction in depression severity at 3 months postpartum indicates a positive outcome.

    3 months

Secondary Outcomes (1)

  • Participant engagement

    6 weeks

Study Arms (3)

Standard of Care (SoC)

ACTIVE COMPARATOR

Standard of Care for Postpartum Hypertension

Other: SoC

Remote Medical Model (RMM)

EXPERIMENTAL

Includes SoC plus RMM

Other: Remote Medical Model (RMM)Other: SoC

Community Health Model (CHM)

EXPERIMENTAL

Includes SoC, RMM plus CHM

Other: Remote Medical Model (RMM)Other: Community Health Model (CHM)Other: SoC

Interventions

Remote home blood pressure (BP) monitoring once a day for the first 7 days and then at least weekly or more frequently as per a standardized blood pressure protocol up to six weeks and weekly virtual visits for 6 weeks and up to 12 weeks as needed by a physician extender (e.g. Nurse Practitioner, Pharmacist, etc.), and screening for social determinants of health and anxiety/ depression with referral for services if positive

Community Health Model (CHM)Remote Medical Model (RMM)

Utilization of community health workers trained in a strength-based trauma informed dyadic evidence-based approach.

Community Health Model (CHM)
SoCOTHER

SoC for Postpartum Hypertension

Community Health Model (CHM)Remote Medical Model (RMM)Standard of Care (SoC)

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Delivery of singleton live birth (twins reduced to singleton or with vanishing twin syndrome prior to 14 weeks qualify)
  • Postpartum
  • English or Spanish speaking
  • Viable pregnancy 24 weeks of gestation or above (Child can be in NICU to participate)
  • Medicaid or the equivalent within each state (for example, Connecticut has Husky insurance) or uninsured
  • Must living in one of the three states involved in this study (Connecticut, Massachusetts, New York) and preferably within the geographical area of each of the hospitals

You may not qualify if:

  • Multifetal pregnancy (since are they at increased risk for key outcomes)
  • Gestational age \<24 weeks;
  • Known major fetal anomaly in current pregnancy or stillbirth
  • Actively using illicit/illegal substances (such as cocaine, heroin and other types of illicit opiates such as fentanyl) as noted in delivery hospitalization notes
  • Active suicidal ideation with intent and plan
  • Known primary psychotic disorder (i.e. schizophrenia, or schizoaffective disorder)
  • Plans to move out of the state within 6 months
  • Incapable of consent
  • Severe medical complications that don't allow a mother to do the study effectively (for example, active treatment for cancer, dialysis etc. )
  • Physician or provider refusal
  • Patient refusal
  • Incarcerated or institutionalized
  • Stillbirth
  • Births that result in the newborn being under the care of another person or institution other than the birthing individual (e.g. adoption, state involvement) will be evaluated on an individual basis to determine if that person should be included.
  • For participants without access to a phone, we will explore if there are options that will allow them to have access to a devise for the times when they need to communicate with the study team. If not, they will not be able to participate in the study since this study requires phone or telehealth communication with research staff and/or APPs, and CHWs depending on study phase.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Yale New Haven Hospital

New Haven, Connecticut, 06520, United States

RECRUITING

University of Massachusetts Memorial Health

Worcester, Massachusetts, 01655, United States

RECRUITING

Oishei Children's Hospital University at Buffalo

Buffalo, New York, 14203, United States

RECRUITING

Study Officials

  • Rafael Pérez-Escamilla, PhD

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rafael Pérez-Escamilla, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study population will include adult postpartum women at least 18 yrs old that are at-risk for hypertension and/or poor mental health outcomes. This is a multi-site intervention study that follows a sequential stepped-wedge design with the 3 hospitals randomized to their start time for the first arm followed by the second and third arms.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2023

First Posted

June 1, 2023

Study Start

June 12, 2023

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

April 9, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations